Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Kendall, S. Schumacher, C. Denkinger, D. Dowdy (2017)
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling studyPLoS Medicine, 14
Thu Phạm, J. Peter, F. Mello, T. Parraga, N. Lan, P. Nabeta, E. Valli, T. Cáceres, K. Dheda, S. Dorman, D. Hillemann, C. Gray, M. Perkins (2018)
Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre studyInternational Journal of Infectious Diseases, 68
K. Steingart, Ian Schiller, D. Horne, M. Pai, C. Boehme, N. Dendukuri (2014)
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsThe Cochrane Database of Systematic Reviews, 2014
C. Yoon, F. Semitala, E. Atuhumuza, J. Katende, S. Mwebe, L. Asege, D. Armstrong, A. Andama, A. Andama, D. Dowdy, J. Davis, Laurence Huang, M. Kamya, A. Cattamanchi (2017)
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy studyThe Lancet. Infectious diseases, 17
Yingda Xie, S. Chakravorty, D. Armstrong, S. Hall, L. Via, T. Song, Xing Yuan, Xiaoying Mo, H. Zhu, P. Xu, Q. Gao, Myung‐hee Lee, Jongseok Lee, Laura Smith, Ray Chen, J. Joh, Youngsoo Cho, Xin Liu, Xianglin Ruan, L. Liang, N. Dharan, Sang-Nae Cho, C. Barry, J. Ellner, S. Dorman, D. Alland (2017)
Evaluation of a Rapid Molecular Drug‐Susceptibility Test for TuberculosisThe New England Journal of Medicine, 377
L. Paris, R. Magni, Fatima Zaidi, R. Araujo, Neal Saini, M. Harpole, J. Coronel, D. Kirwan, H. Steinberg, R. Gilman, E. Petricoin, R. Nisini, A. Luchini, L. Liotta (2017)
Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severityScience Translational Medicine, 9
J. Minion, E. Leung, Elizabeth Talbot, K. Dheda, M. Pai, D. Menzies (2011)
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysisEuropean Respiratory Journal, 38
L. Scott, A. David, L. Noble, M. Nduna, P. Silva, A. Black, F. Venter, W. Stevens (2017)
Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South AfricaJournal of Clinical Microbiology, 55
M. Rangaka, R. Wilkinson, J. Glynn, A. Boulle, G. Cutsem, R. Goliath, S. Mathee, G. Maartens (2012)
Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 12
S. Chakravorty, A. Simmons, M. Rowneki, Heta Parmar, Yuan Cao, J. Ryan, P. Banada, Srinidhi Deshpande, S. Shenai, A. Gall, J. Glass, Barry Krieswirth, S. Schumacher, P. Nabeta, N. Tukvadze, C. Rodrigues, A. Skrahina, E. Tagliani, D. Cirillo, A. Davidow, C. Denkinger, D. Persing, R. Kwiatkowski, Martin Jones, D. Alland (2017)
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingmBio, 8
S. Wang, X. Ou, Qiang Li, Huiwen Zheng, Yu Wang, Y. Zhao (2016)
The Abbott RealTime MTB assay and the Cepheid GeneXpert assay show comparable performance for the detection of Mycobacterium tuberculosis in sputum specimens.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 45
D. Zak, A. Penn-Nicholson, T. Scriba, E. Thompson, S. Suliman, L. Amon, H. Mahomed, Mzwandile Erasmus, Wendy Whatney, G. Hussey, D. Abrahams, F. Kafaar, T. Hawkridge, S. Verver, E. Hughes, M. Ota, J. Sutherland, R. Howe, H. Dockrell, W. Boom, B. Thiel, T. Ottenhoff, H. Mayanja-Kizza, A. Crampin, K. Downing, M. Hatherill, Joe Valvo, Smitha Shankar, S. Parida, S. Kaufmann, G. Walzl, A. Aderem, W. Hanekom (2016)
A prospective blood RNA signature for tuberculosis disease riskLancet (London, England), 387
G. Theron, R. Venter, G. Calligaro, Liezel Smith, J. Limberis, R. Meldau, D. Chanda, A. Esmail, J. Peter, K. Dheda (2016)
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 8
S. Suliman, E. Thompson, J. Sutherland, J. Weiner, M. Ota, Smitha Shankar, A. Penn-Nicholson, B. Thiel, Mzwandile Erasmus, J. Maertzdorf, Fergal Duffy, P. Hill, J. Hughes, K. Stanley, K. Downing, Michelle Fisher, Joe Valvo, S. Parida, G. Spuy, G. Tromp, Ifedayo Adetifa, S. Donkor, R. Howe, H. Mayanja-Kizza, Henry Boom, H. Dockrell, T. Ottenhoff, M. Hatherill, A. Aderem, W. Hanekom, T. Scriba, S. Kaufmann, D. Zak, G. Walzl (2018)
Four‐Gene Pan‐African Blood Signature Predicts Progression to TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 197
S. Dorman, S. Schumacher, D. Alland, P. Nabeta, D. Armstrong, Bonnie King, Sandra Hall, S. Chakravorty, D. Cirillo, N. Tukvadze, N. Bablishvili, Wendy Stevens, Lesley Scott, Camilla Rodrigues, M. Kazi, Moses Joloba, L. Nakiyingi, M. Nicol, Y. Ghebrekristos, I. Anyango, W. Murithi, R. Dietze, Renata Peres, A. Skrahina, Vera Auchynka, K. Chopra, M. Hanif, Xin Liu, Xing Yuan, C. Boehme, J. Ellner, C. Denkinger, Susan Hal, S. Dorman, S. Schumacher, D. Alland, P. Nabeta, D. Armstrong, Bonnie King, Sandra Hall, S. Chakravorty, D. Cirillo, N. Tukvadze, N. Bablishvili, Wendy Stevens, Lesley Scott, Camilla Rodrigues, M. Kazi, Moses Joloba, L. Nakiyingi, M. Nicol, Y. Ghebrekristos, I. Anyango, W. Murithi, R. Dietze, R. Peres, A. Skrahina, Vera Auchynka, K. Chopra, M. Hanif, Xin Liu, Xing Yuan, C. Boehme, J. Ellner, C. Denkinger, Y. Manabe, D. Hom, R. Aspindzelashvili, A. David, Utkarsha Surve, L. Kamulegeya, Sheila Nabweyambo, S. Surtie, Nchimunya Hapeela, K. Cain, J. Agaya, K. McCarthy, P. Marques-Rodrigues, Luiz Castellani, P. Almeida, Paola Aguiar, V. Solodovnikova, Xianglin Ruan, L. Liang, Guolong Zhang, H. Zhu, Yingda Xie (2018)
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studyThe Lancet. Infectious Diseases, 18
L. Nakiyingi, V. Moodley, Y. Manabe, M. Nicol, Molly Holshouser, D. Armstrong, Widaad Zemanay, W. Sikhondze, Olive Mbabazi, B. Nonyane, M. Shah, M. Joloba, D. Alland, J. Ellner, S. Dorman (2014)
Diagnostic Accuracy of a Rapid Urine Lipoarabinomannan Test for Tuberculosis in HIV-Infected AdultsJAIDS Journal of Acquired Immune Deficiency Syndromes, 66
A. Gupta-Wright, Jurgens Peters, C. Flach, S. Lawn (2016)
Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysisBMC Medicine, 14
J. Peter, L. Zijenah, D. Chanda, P. Clowes, K. Dheda (2016)
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trialThe Lancet, 387
Y. Gardee, A. Dreyer, H. Koornhof, S. Omar, P. Silva, Z. Bhyat, N. Ismail (2016)
Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South AfricaJournal of Clinical Microbiology, 55
A. Sandgren, Michael Strong, P. Muthukrishnan, B. Weiner, G. Church, M. Murray (2009)
Tuberculosis Drug Resistance Mutation DatabasePLoS Medicine, 6
V. Hinić, Kinga Feuz, S. Turan, A. Berini, R. Frei, K. Pfeifer, D. Goldenberger (2017)
Clinical evaluation of the Abbott RealTime MTB Assay for direct detection of Mycobacterium tuberculosis-complex from respiratory and non-respiratory samples.Tuberculosis, 104
S. Chakravorty, Sandy Roh, J. Glass, Laura Smith, A. Simmons, K. Lund, S. Lokhov, Xin Liu, P. Xu, Guolong Zhang, L. Via, Qingyu Shen, Xianglin Ruan, Xing Yuan, H. Zhu, Ekaterina Viazovkina, S. Shenai, M. Rowneki, Jong Lee, C. Barry, Q. Gao, D. Persing, Robert Kwiatkawoski, Martin Jones, A. Gall, D. Alland (2016)
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care UseJournal of Clinical Microbiology, 55
S. Lawn, D. Edwards, K. Kranzer, M. Vogt, L. Bekker, R. Wood (2009)
Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution diseaseAIDS, 23
Angela Starks, Enrique Avilés, D. Cirillo, C. Denkinger, D. Dolinger, C. Emerson, Jim Gallarda, D. Hanna, P. Kim, R. Liwski, P. Miotto, M. Schito, M. Zignol (2015)
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 61Suppl 3
Noremylia Bakhori, N. Yusof, J. Abdullah, Helmi Wasoh, S. Noor, Nurul Raston, F. Mohammad (2018)
Immuno Nanosensor for the Ultrasensitive Naked Eye Detection of TuberculosisSensors (Basel, Switzerland), 18
N. Bahr, E. Nuwagira, Emily Evans, F. Cresswell, Philip Bystrom, A. Byamukama, Sarah Bridge, A. Bangdiwala, D. Meya, C. Denkinger, C. Muzoora, D. Boulware, Darlisha H, Darlisha Williams, Kabanda Taseera, D. Nyehangane, Mugisha Ivan, P. Orikiriza, Joshua Rhein, K. Hullsiek, A. Musubire, K. Pastick, P. Nabeta, J. Mwesigye, R. Rajasingham (2018)
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort studyThe Lancet. Infectious Diseases, 18
C. Boehme, P. Nabeta, D. Hillemann, M. Nicol, S. Shenai, F. Krapp, J. Allen, Rasim Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, Martin Jones, S. O’Brien, D. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, M. Perkins (2010)
Rapid molecular detection of tuberculosis and rifampin resistance.The New England journal of medicine, 363 11
J. Kostera, G. Leckie, N. Tang, J. Lampinen, Magdalena Szostak, K. Abravaya, H. Wang (2016)
Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.Tuberculosis, 101
G. Theron, R. Venter, Liezel Smith, A. Esmail, P. Randall, Vishesh Sood, Suzette Oelfese, G. Calligaro, R. Warren, K. Dheda (2018)
False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical OutcomesJournal of Clinical Microbiology, 56
Peter Daley, Joy Michael, P. Hmar, A. Latha, P. Chordia, D. Mathai, K. John, Madhukar Pai (2009)
Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 13 8
M. Berry, C. Graham, Finlay Mcnab, Zhaohui Xu, S. Bloch, T. Oni, K. Wilkinson, R. Banchereau, Jason Skinner, R. Wilkinson, Charlie Quinn, D. Blankenship, R. Dhawan, J. Cush, A. Mejías, O. Ramilo, O. Kon, V. Pascual, J. Banchereau, D. Chaussabel, A. O’Garra (2010)
An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human TuberculosisNature, 466
Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 REVIEW URRENT PINION Susan E. Dorman Purpose of review The current review highlights recent advances in tuberculosis (TB) diagnostics that are relevant for clinicians engaged in the care of HIV-positive adults. Recent findings The first section focuses on newly available tools, highlighting recent progress. The second section focuses on new diagnostic approaches that are not yet widely available or implemented, but have considerable potential to improve the management of TB/HIV coinfected persons. The final section speculates about future directions that may be fruitful. Summary Advances in Mycobacterium tuberculosis nucleic acid amplification-based genotypic tests stand to improve case detection and drug susceptibility testing in the near term. Identification of human gene expression signatures that are associated with TB and/or TB risk, and the identification of novel M. tuberculosis targets coupled with exploitation of advances in biosensor technology may transform TB diagnosis in the future. Keywords diagnosis, diagnostics, HIV, tuberculosis INTRODUCTION NEW TOOLS THAT HAVE ENTERED CLINICAL PRACTICE Tuberculosis (TB) in people living with HIV (PLHIV) has several facets that warrant special consideration Nucleic acid amplification tests during the development and clinical application of The cardinal features of nucleic acid amplification TB diagnostic tests.
Current Opinion in HIV & AIDS – Wolters Kluwer Health
Published: Nov 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.